Multiple Ascending Dose Study on Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects or Subjects With Schizophrenia or Schizoaffective

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions

Schizophrenia or Schizoaffective Disorder

Interventions

DRUG

AMG 581

Active drug

DRUG

Placebo

DRUG

Midazolam

Interaction

Trial Locations (2)

Research Site, Glendale

Parexel, Glendale